refer_colleagues_head
Provide the necessary information and use the automated message, or type a message
to your colleague(s).

* Represents a required field
* Your First Name:
* Your Last Name:
* Your Email:
* Your Designation:
* Colleague Name #1:
* Colleague Email #1:
  Colleague Name #2:
  Colleague Email #2:
  Colleague Name #3:
  Colleague Email #3:
Standard Message Preview
I thought you would like to know about the new Web site for ParaGard® T 380A (intrauterine copper contraceptive), which offers a wealth of resources for you and your patients. As you may already know, ParaGard® can offer your patients highly effective hormone-free birth control with no demanding daily or weekly routines. To access the new site, click here.
Additional Personal Message (optional)
Click here to preview your message.
Please send me a copy of this message.
This data will only be used to send this message to your colleague. It will not be kept on file or used for any other purpose than sending this email.

Sending this email to your colleague does not mean that you or he/she have signed up to receive more information from ParaGard®.

To learn more about our communications standards, please read our Privacy Policy.
ParaGard® Important Safety Information
Click here to view the full ParaGard® Prescribing Information

ParaGard® does not protect against HIV/AIDS or other sexually transmitted infections. ParaGard® must not be used by women who are or may be pregnant; have acute pelvic inflammatory disease (PID) or current behavior suggesting a high risk for PID; have had a postpregnancy or postabortion uterine infection in the past 3 months; have cancer of the uterus or cervix; have an infection in the cervix; have an allergy to any component; or have Wilson's disease. The most common side effects of ParaGard® are heavier and longer periods and spotting between periods; for most women, these typically subside after 2 to 3 months. If a woman misses her period, she must be promptly evaluated for pregnancy. Some possible serious complications that have been associated with intrauterine contraceptives, including ParaGard®, are PID, perforation of the uterus, and expulsion.